Kalil G. Abdullah, MD

Kalil G. Abdullah, MD, MSc, is a neurosurgeon specializing in the treatment of adult brain tumors and is the director of Translational Neuro-Oncology Laboratory at the UPMC Hillman Cancer Center.

Dr. Abdullah treats brain tumors using open, endoscopic and tubular approaches, intraoperative fluorescence, laser therapy, and stereotactic radiosurgery to provide minimally invasive surgery options to his patients.

Dr. Abdullah is an NIH-funded investigator developing new drug and treatment targets for brain cancers. He has been an investigator for numerous clinical trials for glioma and is actively involved in bringing promising brain tumor drugs from the laboratory to early-stage clinical trials. He has published more than 100 research articles including key neuro oncology advances in journals such as Neuro-Oncology, Cancer Cell, Clinical Cancer Research, Nature Medicine, and Nature.

Dr. Abdullah earned his medical degree at the Cleveland Clinic Lerner College of Medicine, where he was a National Institutes of Health Howard Hughes Medical Institute Scholar. He completed a residency in neurological surgery at the University of Pennsylvania and then received advanced training in neurosurgical oncology through a fellowship at the Wellington Hospital in New Zealand. He completed an additional postdoctoral research fellowship in stem cell biology at the University of Pennsylvania, and holds a master’s degree from the London School of Economics.